Jina Lee1, Gregory A Storch. 1. From the *Department of Pediatrics, Washington University School of Medicine, St. Louis, MO; and †Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Abstract
BACKGROUND: Multiplex molecular assays now make it possible for clinical laboratories to detect human coronaviruses (HCoVs). We investigated the clinical characteristics of HCoV-OC43 and HCoV-NL63 in patients <5 years of age during a recent coronavirus season. METHODS: Respiratory viruses were detected using a multiplex molecular assay at St. Louis Children`s Hospital starting in November 2012. We analyzed demographic and clinical data from all patients <5 years of age with solo detection of HCoV-OC43 (n = 52) and HCoV-NL63 (n = 44) and for comparison, samples of children with respiratory syncytial virus, parainfluenza virus and picornaviruses. RESULTS: During the study period, HCoV-OC43 (4%) was the 5th and HCoV-NL63 the 8th (2%) most common respiratory virus. Coinfections were detected in 35% and 38% of children with HCoV-OC43 and HCoV-NL63, respectively. Croup was more common with HCoV-NL63 (30%) than with HCoV-OC43 (2%). Lower respiratory tract infection occurred in 33% of children with HCoV-OC43 and 25% of children with HCoV-NL63. Severe illness was less common in HCoV-NL63, HCoV-OC43 and parainfluenza virus (14%, each) compared with respiratory syncytial virus (30%) and picornaviruses (26%; P = 0.055 for HCoVs combined compared with the other respiratory viruses) and occurred mainly in those with underlying medical conditions. CONCLUSIONS: Infections caused by HCoV-OC43 and HCoV-NL63 are common and include some with lower respiratory tract involvement and severe disease, especially in children with underlying medical conditions. Overall, a substantial burden of disease associated with both HCoV-OC43 and HCoV-NL63 was observed for hospitalized children <5 years of age.
BACKGROUND: Multiplex molecular assays now make it possible for clinical laboratories to detect human coronaviruses (HCoVs). We investigated the clinical characteristics of HCoV-OC43 and HCoV-NL63 in patients <5 years of age during a recent coronavirus season. METHODS:Respiratory viruses were detected using a multiplex molecular assay at St. Louis Children`s Hospital starting in November 2012. We analyzed demographic and clinical data from all patients <5 years of age with solo detection of HCoV-OC43 (n = 52) and HCoV-NL63 (n = 44) and for comparison, samples of children with respiratory syncytial virus, parainfluenza virus and picornaviruses. RESULTS: During the study period, HCoV-OC43 (4%) was the 5th and HCoV-NL63 the 8th (2%) most common respiratory virus. Coinfections were detected in 35% and 38% of children with HCoV-OC43 and HCoV-NL63, respectively. Croup was more common with HCoV-NL63 (30%) than with HCoV-OC43 (2%). Lower respiratory tract infection occurred in 33% of children with HCoV-OC43 and 25% of children with HCoV-NL63. Severe illness was less common in HCoV-NL63, HCoV-OC43 and parainfluenza virus (14%, each) compared with respiratory syncytial virus (30%) and picornaviruses (26%; P = 0.055 for HCoVs combined compared with the other respiratory viruses) and occurred mainly in those with underlying medical conditions. CONCLUSIONS: Infections caused by HCoV-OC43 and HCoV-NL63 are common and include some with lower respiratory tract involvement and severe disease, especially in children with underlying medical conditions. Overall, a substantial burden of disease associated with both HCoV-OC43 and HCoV-NL63 was observed for hospitalized children <5 years of age.
Authors: Valery Madsen Beau De Rochars; John Lednicky; Sarah White; Julia Loeb; Maha A Elbadry; Taina Telisma; Sonese Chavannes; Marie Gina Anilis; Eleonora Cella; Massimo Ciccozzi; Bernard A Okech; Marco Salemi; J Glenn Morris Journal: Am J Trop Med Hyg Date: 2016-10-31 Impact factor: 2.345
Authors: Bozena Szelazek; Wojciech Kabala; Krzysztof Kus; Michal Zdzalik; Aleksandra Twarda-Clapa; Przemyslaw Golik; Michal Burmistrz; Dominik Florek; Benedykt Wladyka; Krzysztof Pyrc; Grzegorz Dubin Journal: J Virol Date: 2017-05-12 Impact factor: 5.103
Authors: Mathieu Dubé; Alain Le Coupanec; Alan H M Wong; James M Rini; Marc Desforges; Pierre J Talbot Journal: J Virol Date: 2018-08-16 Impact factor: 5.103
Authors: Hygor Trombetta; Heloisa Z Faggion; Jaqueline Leotte; Meri B Nogueira; Luine R R Vidal; Sonia M Raboni Journal: Pathog Glob Health Date: 2016-05-19 Impact factor: 2.894
Authors: Kyu Yeun Kim; Song Yi Han; Ho Seong Kim; Hyang Min Cheong; Sung Soon Kim; Dong Soo Kim Journal: Yonsei Med J Date: 2017-01 Impact factor: 2.759